Healthy Skepticism Library item: 3725
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Epstein RA.
Regulatory paternalism in the market for drugs: lessons from Vioxx and Celebrex.
Yale J Health Policy Law Ethics 2005 Sum; 5:(2):741-70
Keywords:
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use
Chromans/therapeutic use
Clinical Trials
Cyclooxygenase Inhibitors/therapeutic use
Drug Industry/legislation & jurisprudence*
Drug and Narcotic Control/legislation & jurisprudence*
Humans
Hypoglycemic Agents/therapeutic use
Isoxazoles/therapeutic use
Lactones/therapeutic use
Myocardial Infarction/chemically induced
Paternalism*
Platelet Aggregation Inhibitors/therapeutic use
Pyrazoles/therapeutic use
Sulfonamides/therapeutic use
Sulfones/therapeutic use
Thiazolidinediones/therapeutic use
Truth Disclosure*
United States
United States Food and Drug Administration/legislation & jurisprudence*
Vasodilator Agents/therapeutic use
